Filed: 5/15/2025ACC: 0000919574-25-003127
📋 What this filing means
CAXTON CORP filed this quarterly 13F‑HR report disclosing 12 equity positions with a total reported market value of $5.08M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
12
Positions
$5.08M
Total AUM (reported)
1.52M
Total Shares
Allocation by class
COM NEW$4.06M79.9%
COM$397.6K7.8%
GOLD SHS$374.1K7.4%
CL B NEW$248.8K4.9%
Portfolio Concentration
Top 3$4.45M87.5%
4–10$608.4K12.0%
11–25$24.5K0.5%
Top 3 weight
87.5%
Top 10 weight
99.5%
Voting Authority Distribution
Total shares with voting rights: 1.52M
Sole
Full voting authority
1.52M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole12
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings12
Rows:
REZOLUTE INC
SOLEShares1.32M
TypeSH
Market value$3.83M
75.28%
Sole
1.32M
Shared
0.00
None
0.00
SPDR GOLD TR
SOLEShares1.30K
TypeSH
Market value$374.1K
7.36%
Sole
1.30K
Shared
0.00
None
0.00
BERKSHIRE HATHAWAY INC DEL
SOLEShares467.00
TypeSH
Market value$248.8K
4.90%
Sole
467.00
Shared
0.00
None
0.00
MIND MEDICINE MINDMED INC
SOLEShares34.07K
TypeSH
Market value$199.3K
3.92%
Sole
34.07K
Shared
0.00
None
0.00
BICARA THERAPEUTICS INC
SOLEShares10.94K
TypeSH
Market value$142.6K
2.81%
Sole
10.94K
Shared
0.00
None
0.00
COMPASS THERAPEUTICS INC
SOLEShares43.47K
TypeSH
Market value$82.6K
1.63%
Sole
43.47K
Shared
0.00
None
0.00
LEXEO THERAPEUTICS INC
SOLEShares17.85K
TypeSH
Market value$61.9K
1.22%
Sole
17.85K
Shared
0.00
None
0.00
KYVERNA THERAPEUTICS INC
SOLEShares22.98K
TypeSH
Market value$44.4K
0.87%
Sole
22.98K
Shared
0.00
None
0.00
CARDIFF ONCOLOGY INC
SOLEShares13.29K
TypeSH
Market value$41.7K
0.82%
Sole
13.29K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares16.39K
TypeSH
Market value$35.9K
0.71%
Sole
16.39K
Shared
0.00
None
0.00
ADICET BIO INC
SOLEShares17.49K
TypeSH
Market value$13.2K
0.26%
Sole
17.49K
Shared
0.00
None
0.00
CONTEXT THERAPEUTICS INC
SOLEShares18.40K
TypeSH
Market value$11.3K
0.22%
Sole
18.40K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REZOLUTE INCSOLE | COM NEW | 1.32M | SH | $3.83M 75.28% | 1.32M | 0.00 | 0.00 |
SPDR GOLD TRSOLE | GOLD SHS | 1.30K | SH | $374.1K 7.36% | 1.30K | 0.00 | 0.00 |
BERKSHIRE HATHAWAY INC DELSOLE | CL B NEW | 467.00 | SH | $248.8K 4.90% | 467.00 | 0.00 | 0.00 |
MIND MEDICINE MINDMED INCSOLE | COM NEW | 34.07K | SH | $199.3K 3.92% | 34.07K | 0.00 | 0.00 |
BICARA THERAPEUTICS INCSOLE | COM | 10.94K | SH | $142.6K 2.81% | 10.94K | 0.00 | 0.00 |
COMPASS THERAPEUTICS INCSOLE | COM | 43.47K | SH | $82.6K 1.63% | 43.47K | 0.00 | 0.00 |
LEXEO THERAPEUTICS INCSOLE | COM | 17.85K | SH | $61.9K 1.22% | 17.85K | 0.00 | 0.00 |
KYVERNA THERAPEUTICS INCSOLE | COM | 22.98K | SH | $44.4K 0.87% | 22.98K | 0.00 | 0.00 |
CARDIFF ONCOLOGY INCSOLE | COM | 13.29K | SH | $41.7K 0.82% | 13.29K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 16.39K | SH | $35.9K 0.71% | 16.39K | 0.00 | 0.00 |
ADICET BIO INCSOLE | COM | 17.49K | SH | $13.2K 0.26% | 17.49K | 0.00 | 0.00 |
CONTEXT THERAPEUTICS INCSOLE | COM | 18.40K | SH | $11.3K 0.22% | 18.40K | 0.00 | 0.00 |